BHVN
Price
$16.21
Change
+$0.32 (+2.01%)
Updated
Sep 3 closing price
Capitalization
1.71B
75 days until earnings call
SRPT
Price
$18.95
Change
+$0.79 (+4.35%)
Updated
Sep 3 closing price
Capitalization
1.98B
55 days until earnings call
Interact to see
Advertisement

BHVN vs SRPT

Header iconBHVN vs SRPT Comparison
Open Charts BHVN vs SRPTBanner chart's image
Biohaven
Price$16.21
Change+$0.32 (+2.01%)
Volume$2.43M
Capitalization1.71B
Sarepta Therapeutics
Price$18.95
Change+$0.79 (+4.35%)
Volume$8.06M
Capitalization1.98B
BHVN vs SRPT Comparison Chart in %
Loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHVN vs. SRPT commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a StrongBuy and SRPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (BHVN: $16.21 vs. SRPT: $18.95)
Brand notoriety: BHVN: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 126% vs. SRPT: 56%
Market capitalization -- BHVN: $1.71B vs. SRPT: $1.98B
BHVN [@Biotechnology] is valued at $1.71B. SRPT’s [@Biotechnology] market capitalization is $1.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, both BHVN and SRPT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 6 TA indicator(s) are bullish while SRPT’s TA Score has 5 bullish TA indicator(s).

  • BHVN’s TA Score: 6 bullish, 3 bearish.
  • SRPT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BHVN is a better buy in the short-term than SRPT.

Price Growth

BHVN (@Biotechnology) experienced а +3.91% price change this week, while SRPT (@Biotechnology) price change was +4.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

BHVN is expected to report earnings on Nov 18, 2025.

SRPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($1.98B) has a higher market cap than BHVN($1.72B). BHVN YTD gains are higher at: -56.600 vs. SRPT (-84.415). SRPT has higher annual earnings (EBITDA): 36.1M vs. BHVN (-792.68M). SRPT has more cash in the bank: 800M vs. BHVN (405M). BHVN has less debt than SRPT: BHVN (292M) vs SRPT (1.35B). SRPT has higher revenues than BHVN: SRPT (2.48B) vs BHVN (0).
BHVNSRPTBHVN / SRPT
Capitalization1.72B1.98B87%
EBITDA-792.68M36.1M-2,196%
Gain YTD-56.600-84.41567%
P/E RatioN/A27.21-
Revenue02.48B-
Total Cash405M800M51%
Total Debt292M1.35B22%
FUNDAMENTALS RATINGS
BHVN vs SRPT: Fundamental Ratings
BHVN
SRPT
OUTLOOK RATING
1..100
733
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
6466
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a16

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRPT's Valuation (57) in the Biotechnology industry is in the same range as BHVN (65) in the Pharmaceuticals Major industry. This means that SRPT’s stock grew similarly to BHVN’s over the last 12 months.

SRPT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BHVN (100) in the Pharmaceuticals Major industry. This means that SRPT’s stock grew similarly to BHVN’s over the last 12 months.

SRPT's SMR Rating (93) in the Biotechnology industry is in the same range as BHVN (100) in the Pharmaceuticals Major industry. This means that SRPT’s stock grew similarly to BHVN’s over the last 12 months.

BHVN's Price Growth Rating (64) in the Pharmaceuticals Major industry is in the same range as SRPT (66) in the Biotechnology industry. This means that BHVN’s stock grew similarly to SRPT’s over the last 12 months.

BHVN's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as SRPT (100) in the Biotechnology industry. This means that BHVN’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHVNSRPT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 23 days ago
74%
Declines
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
74%
Bearish Trend 1 day ago
71%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARRFX14.320.04
+0.28%
AMG River Road Focused Absolute Value N
PJGZX23.350.02
+0.09%
PGIM Jennison Focused Value Z
FFNAX13.82N/A
N/A
Fidelity Advisor Asset Manager 40% A
GSATX34.94N/A
N/A
Goldman Sachs Small Cp Val Insghts A
ACSHX31.23-0.08
-0.26%
Invesco Comstock R5

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with SYRE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+2.01%
SYRE - BHVN
52%
Loosely correlated
+1.08%
CGON - BHVN
50%
Loosely correlated
+4.41%
BEAM - BHVN
49%
Loosely correlated
+15.02%
CRNX - BHVN
48%
Loosely correlated
+4.05%
RVMD - BHVN
46%
Loosely correlated
+0.61%
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with BPMUF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+4.35%
BPMUF - SRPT
52%
Loosely correlated
N/A
AAVXF - SRPT
45%
Loosely correlated
N/A
BHVN - SRPT
37%
Loosely correlated
+2.01%
ROIV - SRPT
36%
Loosely correlated
+1.61%
SNDX - SRPT
36%
Loosely correlated
+0.06%
More